Blog

Kimball Hall is a longtime pharmaceutical industry leader with 30 years of experience in quality, regulatory and manufacturing. Formerly holding leadership positions at Genentech and Amgen, she is currently president and chief operating officer of Abzena, a biologics-focused contract development and manufacturing organization (CDMO). Prior to her role at Abzena, Kimball held several executive positions at Genentech, Inc., a member of the Roche family, most recently as senior vice president, global head of drug substance manufacturing and a member of the Genentech executive committee. Responsible for seven internal sites and 27 external manufacturing locations, she supported five commercial product launches, built a strong quality and safety culture, and established small-volume production. Prior to joining Genentech, Kimball spent 16 years at Amgen, a biotechnology company, most recently as vice president of manufacturing.

Kimball has held a variety of board and advisory board positions, including as a member of Genentech’s patient access board and as an advisor to Genentech’s global women’s professional organization. She holds a bachelor’s degree in microbiology from the University of Washington.